Navigation Links
Discovery opens the door to electricity from microbes
Date:5/23/2011

Using bacteria to generate energy is a signifiant step closer following a breakthrough discovery by scientists at the University of East Anglia (UEA).

Published today by the leading scientific journal Proceedings of the National Academy of Sciences (PNAS), the research demonstrates for the first time the exact molecular structure of the proteins which enable bacterial cells to transfer electrical charge.

The discovery means scientists can now start developing ways to 'tether' bacteria directly to electrodes - creating efficient microbial fuel cells or 'bio-batteries'. The advance could also hasten the development of microbe-based agents that can clean up oil or uranium pollution, and fuel cells powered by human or animal waste.

"This is an exciting advance in our understanding of how some bacterial species move electrons from the inside to the outside of a cell," said Dr Tom Clarke of UEA's School of Biological Sciences.

"Identifying the precise molecular structure of the key proteins involved in this process is a crucial step towards tapping into microbes as a viable future source of electricity."

Funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the US Department of Energy, the project is led by Dr Clarke, Prof David Richardson and Prof Julea Butt of UEA, in collaboration with colleagues at the Pacific Northwest National Laboratory in the US.

In earlier research published by PNAS in 2009, the team demonstrated the mechanism by which bacteria survive in oxygen-free environments by constructing electrical wires that extend through the cell wall and make contact with a mineral a process called iron respiration or 'breathing rocks'. (See http://www.uea.ac.uk/bio/news/rocknews)

In this latest research, the scientists used a technique called x-ray crystallography to reveal the molecular structure of the proteins attached to the surface of a Shewanella oneidensis cell through which electrons are transferred.


'/>"/>

Contact: Simon Dunford
s.dunford@uea.ac.uk
44-160-359-2203
University of East Anglia
Source:Eurekalert

Related biology technology :

1. Veteran Wall Street Securities Analyst Reports on Health Discovery Corporation
2. UMD scientists make magnetic new graphene discovery
3. Search for advanced materials aided by discovery of hidden symmetries in nature
4. Transgenomic Announces Discovery of a Novel Technique Which Enhances Analytic Sensitivity of Standard Sanger Sequencing to 1%
5. Ontario Institute for Cancer Research Announces Investment in Microfluidics Technology for the Discovery of Anti-Cancer Drugs
6. Leaders in Stem Cell Research and Discovery to Share Americas Most Distinguished Prize in Medicine
7. Genomic Health Announces Results from Biomarker Discovery Program Utilizing Next-Generation Sequencing to Compare Normal and Tumor Breast Tissue
8. Alzheimers Drug Discovery Foundation Funds ALS Biopharma to Develop Small Molecules for Alzheimers Disease
9. Sutro Biopharma Forges Partnership with Pfizer for Discovery, Development and Commercialization of Novel Peptide-Based Therapeutics
10. Stem cell discovery could lead to improved bone marrow transplants
11. Thomson Reuters and ChemAxon Partner to Help Speed Drug Discovery for Life Science Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... MILPITAS, Calif. , Feb. 17, 2017 /PRNewswire/ ... posters detailing data on its oral peptide drug ... Congress of the European Crohn,s and Colitis ... in Barcelona, Spain from ... The posters detail preclinical data on Protagonist drug ...
(Date:2/16/2017)... and GREENWICH, Conn. ... private investment firm focused on venture growth investments ... promotion of Josh Richardson , M.D. to ... investments in biotechnology companies.  He is a board ... important roles in Longitude,s investments in Aimmune Therapeutics, ...
(Date:2/16/2017)... , Feb. 16, 2017   Capricor ... a clinical-stage biotechnology company developing first-in-class biological therapies ... that it has elected to terminate its license ... peptide receptor agonists, including Cenderitide. "Our ... move as we prioritize our efforts to advance ...
(Date:2/16/2017)... , Feb. 16, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, today ... 1a financing and entered into a $5 million ... intends to use the capital for general corporate ... advancements in the treatment of serious diseases treated ...
Breaking Biology Technology:
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... MINNETONKA, Minn. , Feb. 7, 2017   ... that supports the entire spectrum of clinical research, is ... iMedNet , its innovative, highly flexible and ... iMedNet customers. iMedNet is a ... only provides Electronic Data Capture (EDC), but also delivers ...
Breaking Biology News(10 mins):